Horizon Discovery Biosciences Limited
Registered name: HORIZON DISCOVERY BIOSCIENCES LIMITED
Part of Wellesley Bv groupHorizon Discovery Biosciences Limited made £49.5m revenue and £13k profit in the year to 28 Dec 2025.
Horizon Discovery Biosciences Limited’s revenue grew 2% to £49.5m in the year to 28 Dec 2025, with £13k profit. The company is classified under “research and experimental development on biotechnology” and is based in Cambridge; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Cambridge
- Age
- 19 yrs · since 2006
- Type
- Private Limited Company
Key figures
Financial history
| Year to | 29 Dec 2023 | 28 Dec 2024 | 29 Dec 2024 | 28 Dec 2025 |
|---|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | £58.9m | £48.5m | £48.5m | £49.5m |
| Cost of sales | −£58.5m | −£47.6m | −£47.6m | −£49.2m |
| Gross profit | £437k | £883k | £883k | £354k |
| Operating profit | £40k | −£9k | −£9k | £10k |
| Profit before tax | £44k | £9k | £9k | £18k |
| Profit after tax | £8k | £7k | £7k | £13k |
| Profit (best available) | £8k | £7k | £7k | £13k |
| Employees (average) | — | — | — | — |
| Ratios | ||||
| Profit margin | 0% | 0% | 0% | 0% |
| Gross margin | 0.7% | 1.8% | 1.8% | 0.7% |
| Growth (year on year) | ||||
| Revenue growth | — | ▼17.7% | — | ▲2.1% |
| Profit growth | — | ▼12.5% | — | ▲85.7% |
| Balance sheet — indirect signals, not revenue | ||||
| Net assets | — | — | — | — |
| Source | Accounts · bulk data Dec 2025 | Accounts · bulk data Oct 2026 | Accounts · bulk data Dec 2025 | Accounts · bulk data Oct 2026 |
How the business works
- Profit margin
- 0%
- Profit ÷ revenue.
- Gross margin
- 0.7%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- —
- Now —
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Wellesley Bv (registered outside the UK register)ultimate parent75–100%
- Revvity (UK) Holdings Limited75–100%
- Horizon Discovery Group Limited75–100%
- Revvity Discovery Limited75–100%
- Horizon Discovery Biosciences Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from accounts for the year to 28 Dec 2025 (profit £13k), from the Companies House accounts bulk data published Oct 2026. Spotted an error? Request a correction.
Updated from Companies House on 20 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.